Skip to main content
Log in

Pharmacogenetics of phenylethylamine: Determination of heritability and genetic transmission of locomotor effects in recombinant inbred strains of mice

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

β-Phenylethylamine (PEA) is an amphetaminelike compound that is postulated to be a possible endogenous psychotogen. We studied locomotor response to PEA in two inbred progenitor strains of mice (C57BL/6 By and BALB/c By), their reciprocal F1 hybrids (B6CF1 and CB6F1), and seven recombinant inbred strains (CXBD, CXBE, CXBG, CXBH, CXBI, CXGJ, and CXBK). Univariate and multivariate statistical analyses were done. Heritability of the response to PEA was 82%. The strain distribution pattern was suggestive of the inheritance of the trait through a single major gene locus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Anderson TW (1958) An introduction to multivariate statistical analysis. Wiley, New York

    Google Scholar 

  • Bailey DW (1971) Recombinant-inbred strains. Transplantation 11:325–327

    Google Scholar 

  • Borison RL, Havdala HS, Diamond BI (1977a) Chronic phenylethylamine stereotypy in rats: A new animal model of schizophrenia? Life Sci 21:117–122

    Google Scholar 

  • Borison RL, Reyes M, Lemus F (1977b) Regional localization of 2-phenylethylamine in human brain. Res Commun Psychiatr Behav 2:193–201

    Google Scholar 

  • Bochme RE, Ciaranello RD (1982) Genetic control of dopamine and serotonin receptors in brain regions of inbred mice. Brain Res 21:51–65

    Google Scholar 

  • Eleftheriou BE, Elias PK (1975) Recombinant inbred strains: A novel genetic approach for psychopharmacogenetics. In: Eleftheriou BE (ed) Psychopharmacogenetics. Plenum, New York, pp 43–71

    Google Scholar 

  • Fink JS, Smith GP (1980) Mesolimbicocortical dopamine terminal fields are necessary for normal locomotor and investigatory exploration in rats. Brain Res 199:359–384

    Google Scholar 

  • Jeste DV, Doongaji DR, Panjwani D, Datta M, Potkin SG, Karoum F, Thatte S, Apte JS, Wyatt RJ (1981) Cross-cultural study of a biochemical abnormality in paranoid schizophrenia. Psychiatr Res 139:341–352

    Google Scholar 

  • Moisset B (1977a) Genetic analysis of the behavioral response to d-amphetamine in mice. Psychopharmacology 53:263–267

    Google Scholar 

  • Moisset B (1977b) Factors contributing to the modulation of norepinephrine uptake by synaptosomes from mouse brain cortex. Brain Res 121:113–120

    Google Scholar 

  • Nurnberger JI, Gershon ES, Simmons S, Ebert M, Kessler LR, Dibble ED, Jimerson SS, Brown GM, Gold P, Jimerson DC, Guroff J, Storch FI (1982) Behavioral, biochemical and neuroendocrine response to amphetamine in normal twins and ‘well-state’ bioplar patients. Psychoneuroendocrinology 7:163–176

    Google Scholar 

  • Oliverio A, Eleftheriou BE, Bailey DW (1973) Exploration activity: Genetic analysis of its modification by scopolamine and amphetamine. Physiol Behav 10:893–899

    Google Scholar 

  • Perlow MJ, Chiueh CC, Lake CR, Wyatt RJ (1980) Increased dopamine and norepinephrine concentrations in primate CSF following amphetamine and phenylethylamine administration. Brain Res 186:469–473

    Google Scholar 

  • Potkin SG, Karoum F, Chuang L, Cannon-Spoor HE, Phillips I, Wyatt RJ (1979) Phenylethylamine in paranoid schizophrenia. Science 206:470–471

    Google Scholar 

  • Reis DJ, Baker H, Fink JS, Joh TH (1979) A genetic control of the number of central dopamine neurons in relationship to brain organization, drug responses, and behavior. In: Usdin E, Kopin IJ, Barchas J (eds) Catecholamines: Basic and clinical frontiers, vol 1. Pergamon, New York, pp 23–33

    Google Scholar 

  • Saavedra JM (1974) Enzymatic isotopic assay for and presence of β-phenylethylamine in brain. J Neurochem 22:211–216

    Google Scholar 

  • Sandler M, Reynolds GP (1976) Does phenylethylamine cause schizophrenia? Lancet 1:70–71

    Google Scholar 

  • Schoemaker H, Nickolson VJ, Kerbusch S, Crabbe JC (1984) Brain Res (in press)

  • Stoff DM, Gale K (1981) β-Phenylethylamine reversal of chlorpromazine-induced activation of striatal tyrosine hydroxylase and catelepsy. Brain Res 211:492–496

    Google Scholar 

  • Wyatt RJ, Gillin JC, Stoff DM, Moja EA, Tinklenberg JR (1977) β-Phenylethylamine and the neuropsychiatric disturbances. In: Usdin E, Hamburg D, Barchas JD (eds) Neuroregulators and psychiatric disorders. Oxford University Press, New York, pp 31–45

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jeste, D.V., Stoff, D.M., Rawlings, R. et al. Pharmacogenetics of phenylethylamine: Determination of heritability and genetic transmission of locomotor effects in recombinant inbred strains of mice. Psychopharmacology 84, 537–540 (1984). https://doi.org/10.1007/BF00431462

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00431462

Key words

Navigation